Actively Recruiting
The Sunnybrook Type 2 Diabetes Study
Led by Sunnybrook Health Sciences Centre · Updated on 2023-04-12
500
Participants Needed
1
Research Sites
466 weeks
Total Duration
On this page
Sponsors
S
Sunnybrook Health Sciences Centre
Lead Sponsor
U
University Health Network, Toronto
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Sunnybrook Type 2 Diabetes Study (S2DS) is a prospective observational study of people with prediabetes or Type 2 Diabetes Mellitus (T2DM), that aims to understand the aetiologies, manifestations, and clinical consequences of mood and cognitive complications. The study recruits from the services at Sunnybrook Health Sciences Centre and from the neighbouring University Health Network Toronto Rehabilitation Institute Cardiac Rehabilitation Program.
CONDITIONS
Official Title
The Sunnybrook Type 2 Diabetes Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have at least one of the following: high HbA1c, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), but not yet diagnosed with Type 2 diabetes or have a diagnosis of Type 2 diabetes.
- Be able to communicate in English
- Be 18 years of age or older
You will not qualify if you...
- Pregnancy
- Inability to give informed consent
- Current cancer diagnosis
- Have a prior diagnosis of bipolar disorder or schizophrenia.
- Have a prior diagnosis of a neurological and/or neurodegenerative disorder.
- Have a current substance use disorder or a previous substance use disorder diagnosed within the last 5 years (excluding nicotine)
- Poor score on the Mini Mental State Examination (MMSE)
- Contraindications to SHSC's MRI safety protocol (for Brain Imaging Sub-Study)
- Use of medical equipment that interferes with CVR mask placement (for Brain Imaging Sub-Study CVR procedure)
- Significant pulmonary disease such as asthma, pulmonary fibrosis, emphysema, COPD, pulmonary vascular disease, pleural disorders, or pneumonia (for Brain Imaging Sub-Study CVR procedure)
- Use of medical devices interfering with portable sleep monitor equipment or requiring O2 therapy via nasal prongs (for Sleep Quality and Apnea Sub-Study)
- Conditions that affect accuracy of sleep apnea testing like moderate-severe pulmonary disease or congestive heart failure (for Sleep Quality and Apnea Sub-Study)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sunnybrook Research Institute
Toronto, Ontario, Canada, M4N 3M5
Actively Recruiting
Research Team
W
Walter Swardfager, PhD
CONTACT
C
Chelsi Major-Orfao, MEd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here